Maria Makarova

Maria Makarova



+ 7 495 545 39 12

Send message

Additionally to participation in Team Drive Marya Maria is Chief Financial Officer at RMI Partners (venture capital investment company) and at pharmaceutical company NovaMedica.

Maria has over 15 years of experience in finance. She started her professional career at one of the "Big 4" companies, where she worked in the audit department for more than 12 years. Subsequently Maria participated in the creation and development of a large management company, where she was responsible for general operational project management of medical services and medical technology, in addition to her financial management responsibilities.

Maria Makarova holds a Bachelor’s degree in Mathematics and Finance, MBA and CPA (US Certified Public Accountant). 

In 2016 and 2017, Maria was listed in the TOP-1000 Russian Managers rating released annually by the Managers Association of Russia and Kommersant Publishing House.

Media Center

  • 25 June 2018

    Researchers unveil “unprecedentedly sensitive” biochips

    Researchers at the Moscow Institute of Physics and Technology (MIPT), a top technology university in Russia, have developed new biosensor chips of “unprecedentedly high sensitivity.” They replaced gold, which is typically used in such devices, with copper. The approach is expected to not only lower the cost of the end solutions but also make biosensor manufacturing technology much simpler, the developers said. 

  • 25 June 2018

    No pharma Grand Prix—again—at Cannes Lions Health, but record number of awards for drugmakers

    For the second year in a row, there is no grand prize winner in the pharma category at Cannes Lions Health. The big idea award, called the Grand Prix, eluded the field again, despite a pharma-heavy short list. But while pharma marketers may be disappointed, they still have plenty of reason to celebrate. Sixteen different pharma companies made the awards shortlist and 10 won gold, silver or bronze Lions. That’s a sharp uptick from last year when only nine were finalists and three picked up awards.

  • 22 June 2018

    Drug shortages again on the rise after 5 years of improvements, FDA says

    After 5 years of declines in the number of new drug shortages in the U.S., they jumped to 39 last year from 26 in the two preceding years. And while that is a far cry from the peak of more than 250 registered in 2011, the FDA acknowledges that many of the current shortages have been for critical drug products and “are having a tangible impact on patients.”

  • 22 June 2018

    Pfizer’s 'Living With Cancer' wowed Cannes attendees, if not the pharma jury

    A Pfizer documentary film about five patients living with cancer may have inspired more fanfare at Cannes Lions Health than it did in the eight months since its launch. The “This is Living With Cancer” film and its associated campaign was shortlisted for a pharma award at the annual ad festival and was heaped with praise after Pfizer presented it in an open session.

Read more